Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
KlikDokter is an Indonesian health platform that lets people consult doctors online, order medicines, and read trusted health information.
KlikDokter is Indonesia's everyday health app: you open it when you feel sick, talk to a doctor on your phone, get a prescription, and have medicine delivered, all without sitting in a clinic waiting room. It also publishes health articles and videos, so a lot of people use it just to look up symptoms or read up on a condition before deciding whether to see anyone at all.
The money comes from a few places. Individuals pay for some consultations and for medicine ordered through the e-pharmacy, and the platform sells health products and services directly. The bigger, steadier customer is often the corporate side: companies buy health benefits and consultation access for their employees, and insurers and other partners plug into the service too. That mix matters, because selling to businesses brings recurring contracts rather than one-off app visits. What makes it interesting is that it sits in the messy middle of Indonesian healthcare. The country has hundreds of millions of people, a thin supply of doctors relative to the population, and long travel times to clinics outside the big cities. A phone-based service can reach people who would otherwise wait days or skip care entirely. KlikDokter has been at this since the early 2010s, which is long enough to build a real brand, and it is now part of the Kalbe group, one of Indonesia's largest pharmaceutical companies — a useful tie-in for the pharmacy side of the business.
The hard part is competition and trust. Telehealth apps are easy to copy, and rivals with deep pockets and big user bases, like GoTo through its Gojek ecosystem and its health services, can bundle similar features into apps people already use every day. Regulators also hold the gate on what can be prescribed online and how patient data must be handled, which shapes what the platform can actually sell. So the company's real edge is not the app itself but the combination of a trusted medical brand, a working pharmacy supply chain, and corporate relationships that are slow and costly to build.
Saved answer · last researched 15 Nov 2026